PeptideDB

SB-423562 351490-27-2

SB-423562 351490-27-2

CAS No.: 351490-27-2

SB-423562 is a short-acting (CaR) antagonist. SB-423562 has potential usefulness in research into osteoporosis.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SB-423562 is a short-acting (CaR) antagonist. SB-423562 has potential usefulness in research into osteoporosis.

Physicochemical Properties


Molecular Formula C26H32N2O4
Molecular Weight 436.54
Exact Mass 436.236
CAS # 351490-27-2
PubChem CID 9910902
Appearance White to off-white solid powder
LogP 3.879
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 11
Heavy Atom Count 32
Complexity 644
Defined Atom Stereocenter Count 1
SMILES

CC(C)(CC1CC2=CC=CC=C2C1)NC[C@H](COC3=C(C=CC(=C3)CCC(=O)O)C#N)O

InChi Key NJBFJCJKWWIKRD-HSZRJFAPSA-N
InChi Code

InChI=1S/C26H32N2O4/c1-26(2,14-19-11-20-5-3-4-6-21(20)12-19)28-16-23(29)17-32-24-13-18(8-10-25(30)31)7-9-22(24)15-27/h3-7,9,13,19,23,28-29H,8,10-12,14,16-17H2,1-2H3,(H,30,31)/t23-/m1/s1
Chemical Name

3-[4-cyano-3-[(2R)-3-[[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]phenyl]propanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone. 2010 Feb;46(2):534-42.


Solubility Data


Solubility (In Vitro) DMSO: 5 mg/mL (11.45 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1 mg/mL (2.29 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 1 mg/mL (2.29 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.2907 mL 11.4537 mL 22.9074 mL
5 mM 0.4581 mL 2.2907 mL 4.5815 mL
10 mM 0.2291 mL 1.1454 mL 2.2907 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.